NBY

Novabay Pharmaceuticals

$0.09

-1.86 (-95.38%)

Analyst Overview

Target Price:

Date: 08.04.2026

$0.85

(+844.44%)

Strong Buy: 0

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Description:

NovaBay Pharmaceuticals, Inc., a medical device company, develops products for the eye care markets in the United States and internationally. The company is headquartered in Emeryville, California.

Exchange:

NYSE MKT

Country:

USA

Sector:

HEALTHCARE

Industry:

BIOTECHNOLOGY

Address:

2000 POWELL STREET, EMERYVILLE, CA, UNITED STATES, 94608

Fiscal year end:

December

Market capitalization:

$51.9 Million

EBITDA:

-$7.58 Million

PERatio:

0.0

EPS:

-28.5

Dividend per share:

$0.00

Dividend yield:

0.0%

Beta:

0.164

Dividends for 10 years

Income Statements for 10 years

Earnings calender

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:

$1,000

How much will you earn in 0 months:

+0%

How much will you get:

$1,000

Prices dates:

09-06-2026: $0.09 and 09-06-2026: $0.09